Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Dr. Amarpreet S. Sawhney - Year 2009

AddedFeb 20, 2024

UpdatedMay 31, 2026

Dr. Amarpreet S. Sawhney - Year 2009

Dr. Amarpreet S. Sawhney - Year 2009

Crunchbase LinkedIn

Dr. Amarpreet S. Sawhney - Year 2009's Career

Instylla

Bedford, MA, US

CEO· C-Suite · Management

Ostial

Campbell, CA, US

Board Member· Board

Imperative Care

Imperative Care

Campbell, CA, US

Board Member· Board

Axtria

Berkeley Heights, NJ, US

Board Member· Board

Incept

Sunnyvale, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Dr. Amarpreet S. Sawhney - Year 2009's Career

Instylla

Series C$63.5M422017Bedford, MA, US

CEO· C-Suite · Management

Leadership at Instylla

Amarpreet SawhneyFounder

Darshana ZaveriBoard Member

Tasneem DohadwalaBoard Member

Similar to Instylla

Instent ConnectionSeattle, WA, USMedical DevicesInstent ConnectionSeattle, WA, US

Creating absorbent stents for GI procedures to improve patient outcomes.

Angel · $7.5k50

EmbolxSunnyvale, CA, USMedical Devicesest. 2013EmbolxSunnyvale, CA, US · est. 2013

Embolx: A medical device startup innovating in cancer treatment with novel embolization microcatheters.

Seed · $2.5M12

EmboMedicsMaple Grove, MN, USMedical Devicesest. 2012EmboMedicsMaple Grove, MN, US · est. 2012

EmboMedics: Developing and commercializing resorbable, drug-loaded embolization devices since 2012.

Pre-Seed · $7.6M5

EmStopBrainerd, MN, USMedical Devicesest. 2021EmStopBrainerd, MN, US · est. 2021

Brainerd-based manufacturer specializing in medical devices.

Ostial

Series C$10.2M172010Campbell, CA, US

Board Member· Board

Similar to Ostial

Ostial SolutionsKalamazoo, MI, USMedical Devicesest. 2003Ostial SolutionsKalamazoo, MI, US · est. 2003

US-based Ostial Solutions, LLC develops and distributes surgical and other medical devices.

NovostentMountain View, CA, USMedical Devices, Stentsest. 2003NovostentMountain View, CA, US · est. 2003

NovoStent Corp: Innovating stent technologies for vascular treatments across the US healthcare sector.

Pre-Seed · $14.4M6

OstiioPhiladelphia, PA, USMedical Devicesest. 2017OstiioPhiladelphia, PA, US · est. 2017

Ostiio: Innovating wireless, precise, fully implantable devices for skeletal correction.

Angel · $281k6

Instent ConnectionSeattle, WA, USMedical DevicesInstent ConnectionSeattle, WA, US

Creating absorbent stents for GI procedures to improve patient outcomes.

Angel · $7.5k50

Imperative Care

Imperative Care

Series D$409M3002015Campbell, CA, US

Board Member· Board

Leadership at Imperative Care

Holly SheffieldBoard Member

Nick HopkinsFounder

Axtria

Late Stage Private$206.2M3.9k2010Berkeley Heights, NJ, US

Board Member· Board

Leadership at Axtria

Richard BraddockBoard Member

Sanjeev AggarwalBoard Member

Navi ChadhaCo-Founder

Jassi ChadhaCo-Founder

Similar to Axtria

AlignAlyticsWayne, PA, USAnalyticsest. 1995AlignAlyticsWayne, PA, US · est. 1995

AlignAlytics: Enhancing business outcomes through advanced analytics software and services.

Angel · $910.3k35

AxonaiHarrisonburg, VA, USCybersecurity, Data Analysisest. 2015AxonaiHarrisonburg, VA, US · est. 2015

AxonAI Inc: A US-based software company specializing in big data analysis and cybersecurity solutions.

DrivenIQTowson, MD, USAnalytics, Dataest. 2019DrivenIQTowson, MD, US · est. 2019

DrivenIQ: A leading data and tech company, enhancing engagement and sales with targeted data solutions.

Series A · $16.2M125

Impact AnalyticsLinthicum, MD, USAI Software, Data Analyticsest. 2015Impact AnalyticsLinthicum, MD, US · est. 2015

Impact Analytics: Turning data into dollars with comprehensive data science solutions.

Series C · $61.8M478

Incept

Investment Firm61998Sunnyvale, CA, US

Co-Founder

Leadership at Incept

Fred KhosraviCo-Founder

People Similar to Dr. Amarpreet S. Sawhney - Year 2009

Soemantri BrodjonegoroBoard Member · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Lau Eng BoonBoard Member · Bukalapak

Nugroho HerucahyonoCo-Founder · Bukalapak

Willix HalimCEO · Bukalapak

Achmad ZakyCo-Founder · Bukalapak

Haeil YiCo-Founder · Dunamu

Lee Sirg-OoCEO · Dunamu

Jeremy CaldwellBoard Member · Odyssey Thera

Peter J LevineBoard Member · Alluxio

Dave OusteroutBoard Member · Inceptor Bio

John BrownellCo-Founder · Submittable

James FlexmanCo-Founder · Knoda

Uday BansalCo-Founder · SkyBulls